Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain.

Hum Vaccin Immunother · 2016 · PMC5027707 · PMID 27184622

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost insignificantno p-value reported

Obviously, if there was almost insignificant type B circulating influenza or if lineage B matching was perfect, QIV would not offer any additional benefit over TIV.

also in 529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.